{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Huntsville",
      "state": "AL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "71646",
      "recalling_firm": "Qualitest Pharmaceuticals",
      "address_1": "120 Vintage Dr NE",
      "address_2": "N/A",
      "postal_code": "35811-8216",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1239-2015",
      "product_description": "HydrOXYzine Hydrochloride Tablets, USP 25 mg,  Rx only, 100 count (NDC 0603-3968-21), 500 count (NDC 0603-3968-28) and 1000 count (NDC 0603-3968-32) bottles, Manufactured for Qualitest Pharmaceuticals, Huntsville, AL",
      "product_quantity": "47,376 bottles",
      "reason_for_recall": "Failed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadable",
      "recall_initiation_date": "20150629",
      "center_classification_date": "20150715",
      "termination_date": "20161023",
      "report_date": "20150722",
      "code_info": "100 count (NDC 0603-3968-21); LOTS# T144F13A, T130G13B, T132G13A, exp date 6/15, T115D14A, exp date 3/16;   500 count (NDC 0603-3968-28), LOT# T144F13B exp date 6/15; and   1000 count (NDC 0603-3968-32); LOTS # T144F13C, T132G13B, exp date 6/15,  T115D14B, exp date 3/16",
      "more_code_info": ""
    }
  ]
}